{"id":6566,"date":"2025-12-26T10:28:08","date_gmt":"2025-12-26T04:58:08","guid":{"rendered":"https:\/\/regisdigitals.com\/client\/Sunact\/?page_id=6566"},"modified":"2026-01-06T00:21:58","modified_gmt":"2026-01-05T18:51:58","slug":"oncovantage-vol-1","status":"publish","type":"page","link":"https:\/\/regisdigitals.com\/client\/Sunact\/oncovantage-vol-1\/","title":{"rendered":"Oncovantage Vol 1"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"6566\" class=\"elementor elementor-6566\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c1a7b2f e-flex e-con-boxed e-con e-parent\" data-id=\"c1a7b2f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-9c22597 e-con-full e-flex e-con e-child\" data-id=\"9c22597\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-55e960e elementor-widget elementor-widget-image\" data-id=\"55e960e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"637\" height=\"116\" src=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/oncovantage.png\" class=\"attachment-full size-full wp-image-6569\" alt=\"\" srcset=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/oncovantage.png 637w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/oncovantage-300x55.png 300w\" sizes=\"(max-width: 637px) 100vw, 637px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-609a0e1 e-con-full e-flex e-con e-child\" data-id=\"609a0e1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4c6343b elementor-widget elementor-widget-heading\" data-id=\"4c6343b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">Volume 1<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fc93f98 elementor-widget elementor-widget-heading\" data-id=\"fc93f98\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">issue 1<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8f1f67f elementor-widget elementor-widget-heading\" data-id=\"8f1f67f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Insights into global breakthroughs in cell-based therapies<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-437dfde e-flex e-con-boxed e-con e-parent\" data-id=\"437dfde\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;gradient&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2ee77a4 e-con-full e-flex e-con e-child\" data-id=\"2ee77a4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1f28ff0 elementor-widget elementor-widget-text-editor\" data-id=\"1f28ff0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Welcome to the SunAct Cancer Research Insights Newsletter, your monthly update on global breakthroughs shaping the next generation of cancer and cell-based therapies.<\/p><p>In this issue, we explore pioneering advances in CGT\/ACT therapy, advancement in detection methods, and regulatory fast-tracks that are accelerating access to life-changing treatments. Our goal is to keep clinicians and researchers informed about innovations redefining patient care worldwide.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b0c6462 e-flex e-con-boxed e-con e-parent\" data-id=\"b0c6462\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-41f4085 e-con-full e-flex e-con e-child\" data-id=\"41f4085\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ec8d4c3 elementor-widget elementor-widget-button\" data-id=\"ec8d4c3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\" arrow_left\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Previous issue<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4de94dc e-con-full e-flex e-con e-child\" data-id=\"4de94dc\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-44718bc elementor-align-right elementor-widescreen-align-right elementor-widget elementor-widget-button\" data-id=\"44718bc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\" arrow_right\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Next issue<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6e70c28 e-flex e-con-boxed e-con e-parent\" data-id=\"6e70c28\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-f8f91d6 e-con-full e-flex e-con e-child\" data-id=\"f8f91d6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-85ae0d3 elementor-widget elementor-widget-heading\" data-id=\"85ae0d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">In Vivo mRNA CAR-T Therapy Targeting Liver Cancer<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-8d6f78f e-con-full e-flex e-con e-child\" data-id=\"8d6f78f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f9610cd elementor-widget elementor-widget-heading\" data-id=\"f9610cd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Technology<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-47ece5d elementor-widget elementor-widget-text-editor\" data-id=\"47ece5d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Direct mRNA delivery via lipid nanoparticles enables in-body generation of CAR-T &#8211; cells targeting GPC3+ hepatocellular carcinoma, no cell harvesting, no lab expansion and just precision immunotherapy activated from within.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-44f2428 elementor-widget elementor-widget-heading\" data-id=\"44f2428\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Clinical Impact\n<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2460917 elementor-widget elementor-widget-text-editor\" data-id=\"2460917\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Delivers functional CAR T-cells without ex vivo cell manufacturing, enabling rapid deployment, reduced manufacturing burden, and targeted cytotoxicity against GPC3+ liver tumors, advancing accessibility in solid tumor immunotherapy.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c627024 e-con-full e-flex e-con e-child\" data-id=\"c627024\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e92c6ff elementor-widget elementor-widget-heading\" data-id=\"e92c6ff\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Why This Matters<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0c0dc53 elementor-widget elementor-widget-text-editor\" data-id=\"0c0dc53\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Bypasses ex-vivo CAR-T production \u2192 treatment-ready within days, not weeks.<\/li><li>Reduces attrition of patients who deteriorate while waiting for cell<br \/>manufacturing.<\/li><li>Opens the door to CAR-T applicability in solid tumors, where accessibility has been limited.<\/li><li>LNP delivery allows repeat dosing, titration, and potentially improved safety control compared to persistent engineered cells.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d2fd8b5 e-flex e-con-boxed e-con e-parent\" data-id=\"d2fd8b5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-743351b e-con-full e-flex e-con e-child\" data-id=\"743351b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0403ead elementor-widget elementor-widget-image\" data-id=\"0403ead\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"2000\" height=\"530\" src=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/3-e1766726080495.jpg\" class=\"attachment-full size-full wp-image-6574\" alt=\"\" srcset=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/3-e1766726080495.jpg 2000w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/3-e1766726080495-300x80.jpg 300w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/3-e1766726080495-1024x271.jpg 1024w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/3-e1766726080495-768x204.jpg 768w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/3-e1766726080495-1536x407.jpg 1536w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-109d476 e-con-full e-flex e-con e-child\" data-id=\"109d476\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-79a6777 elementor-widget elementor-widget-heading\" data-id=\"79a6777\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Take Home Point<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-61824b0 elementor-widget elementor-widget-text-editor\" data-id=\"61824b0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u201cOff-the-shelf\u201d in-body\u2013generated CAR-T could become a realistic option for GPC3+HCC\u2014and eventually other solid tumors\u2014reshaping referral pathways, eligibility timing, and sequencing of systemic therapies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5e7c156 e-flex e-con-boxed e-con e-parent\" data-id=\"5e7c156\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-c8e587d e-con-full e-flex e-con e-child\" data-id=\"c8e587d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ee5db5a elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"ee5db5a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d01f568 elementor-widget elementor-widget-heading\" data-id=\"d01f568\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Next-generation, CRISPR\/Cas9-edited, TIL Therapy for the Treatment of Solid Tumors<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-2f1d9c6 e-con-full e-flex e-con e-child\" data-id=\"2f1d9c6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9c5a92c elementor-widget elementor-widget-heading\" data-id=\"9c5a92c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Technology<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-de5868d elementor-widget elementor-widget-text-editor\" data-id=\"de5868d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Novel CRISPR\/Cas9-edited Tumor-Infiltrating Lymphocytes (TILs) with enhanced cytotoxicity, persistence, and resistance to immunosuppression within solid tumors have been developed.<br \/>This dual-editing strategy reprograms TILs to achieve deeper tumor infiltration and superior anti-tumor activity.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-38a5c4f elementor-widget elementor-widget-heading\" data-id=\"38a5c4f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Clinical Impact\n<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e4c2900 elementor-widget elementor-widget-text-editor\" data-id=\"e4c2900\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"313\" data-end=\"524\"><strong data-start=\"337\" data-end=\"368\">Improved Tumor Eradication:<\/strong> Enhanced cytotoxicity and antigen-specific killing in solid tumors.<br data-start=\"435\" data-end=\"438\" data-is-only-node=\"\" \/><strong data-start=\"440\" data-end=\"475\">Long-Term Therapeutic Activity:<\/strong> Extended TIL survival supports durable responses.<br \/><strong data-start=\"526\" data-end=\"559\">Wider Clinical Applicability:<\/strong> Enables TIL therapy beyond melanoma, with applicability to multiple solid tumor types.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9038869 e-con-full e-flex e-con e-child\" data-id=\"9038869\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-58dcbe5 elementor-widget elementor-widget-heading\" data-id=\"58dcbe5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Why This Matters<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9d2a4ca elementor-widget elementor-widget-text-editor\" data-id=\"9d2a4ca\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Dual CRISPR editing boosts cytotoxicity and infiltration \u2192 may translate into <strong data-start=\"751\" data-end=\"776\">higher response rates<\/strong> in traditionally TIL-refractory solid tumors.<\/li><li>Enhanced persistence \u2192 potential for <strong data-start=\"864\" data-end=\"891\">more durable remissions<\/strong> with fewer re-infusions.<\/li><li>Expands TIL therapy into <strong data-start=\"946\" data-end=\"970\">multiple tumor types<\/strong>, potentially altering treatment sequencing and clinical trial referral patterns.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-647d32c e-flex e-con-boxed e-con e-parent\" data-id=\"647d32c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-46bb767 e-con-full e-flex e-con e-child\" data-id=\"46bb767\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7bd370b elementor-widget elementor-widget-image\" data-id=\"7bd370b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"2000\" height=\"529\" src=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/2.jpg\" class=\"attachment-full size-full wp-image-6579\" alt=\"\" srcset=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/2.jpg 2000w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/2-300x79.jpg 300w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/2-1024x271.jpg 1024w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/2-768x203.jpg 768w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/2-1536x406.jpg 1536w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a566e33 e-con-full e-flex e-con e-child\" data-id=\"a566e33\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b15a42d elementor-widget elementor-widget-heading\" data-id=\"b15a42d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Take Home Point<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d190918 elementor-widget elementor-widget-text-editor\" data-id=\"d190918\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Identify and refer patients with solid tumors earlier for trials using <strong>CRISPR-optimized TILs<\/strong>, as these engineered products may significantly elevate the therapeutic ceiling of adoptive cell therapy in solid malignancies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b34d726 e-flex e-con-boxed e-con e-parent\" data-id=\"b34d726\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-281ea64 e-con-full e-flex e-con e-child\" data-id=\"281ea64\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1159f11 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"1159f11\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f4adcb9 elementor-widget elementor-widget-heading\" data-id=\"f4adcb9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Liquid Biopsy in Lymphoma: Tracking CAR-T Response<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1a3acbf e-con-full e-flex e-con e-child\" data-id=\"1a3acbf\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-040c27d elementor-widget elementor-widget-heading\" data-id=\"040c27d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Technology<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-45a3f8b elementor-widget elementor-widget-text-editor\" data-id=\"45a3f8b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Blood-based liquid biopsy monitors circulating tumor DNA (ctDNA) to assess CAR-T therapy effectiveness in lymphomas like DLBCL and follicular lymphoma. It detects minimal residual disease (MRD) and CAR-T persistence without tissue samples, using genomic and epigenomic markers, delivering results in ~7 days.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3433a2e elementor-widget elementor-widget-heading\" data-id=\"3433a2e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Clinical Impact\n<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5271764 elementor-widget elementor-widget-text-editor\" data-id=\"5271764\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"313\" data-end=\"524\">Recent 2025 data (Clinical Lymphoma Myeloma &amp; Leukemia, August 2025; ASGCT 2025) shows MRD in 89% of cases and predicts progression-free survival with 85% accuracy, spotting relapse 3\u20136 months before imaging. Early intervention based on these insights may boost outcomes by 20\u201330%, with integration into CAR-T protocols underway (NCT05588094, targeting 2026).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-24bb268 e-con-full e-flex e-con e-child\" data-id=\"24bb268\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-edd3713 elementor-widget elementor-widget-heading\" data-id=\"edd3713\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Why This Matters<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-13bcc9b elementor-widget elementor-widget-text-editor\" data-id=\"13bcc9b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Monitoring CAR-T persistence genomically\/epigenomically provides <strong>actionable real-time response assessment.<\/strong><\/li><li>Integration into CAR-T follow-up algorithms is already underway \u2192 oncologists should expect <strong data-start=\"938\" data-end=\"974\">MRD-guided post-CAR-T management<\/strong> to become standard.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e76a3cf e-flex e-con-boxed e-con e-parent\" data-id=\"e76a3cf\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-8af3256 e-con-full e-flex e-con e-child\" data-id=\"8af3256\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-24b6ce9 elementor-widget elementor-widget-image\" data-id=\"24b6ce9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"558\" src=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/1.jpg\" class=\"attachment-full size-full wp-image-6595\" alt=\"\" srcset=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/1.jpg 2000w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/1-300x84.jpg 300w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/1-1024x286.jpg 1024w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/1-768x214.jpg 768w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/1-1536x429.jpg 1536w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-22428d1 e-con-full e-flex e-con e-child\" data-id=\"22428d1\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a1f93f4 elementor-widget elementor-widget-heading\" data-id=\"a1f93f4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Take Home Point<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ed58b2d elementor-widget elementor-widget-text-editor\" data-id=\"ed58b2d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Plan to incorporate <strong>serial ctDNA MRD testing<\/strong> into lymphoma CAR-T follow-up to stratify relapse risk early and personalize post-infusion management.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1dab8d0 e-flex e-con-boxed e-con e-parent\" data-id=\"1dab8d0\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-69adb7b e-con-full e-flex e-con e-child\" data-id=\"69adb7b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fd48e31 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"fd48e31\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-617987e elementor-widget elementor-widget-heading\" data-id=\"617987e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Fast-Track CGT: FDA\u2019s Blueprint for Speed &amp; Impact<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e420f60 elementor-widget elementor-widget-text-editor\" data-id=\"e420f60\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Regulatory initiatives emphasise adaptive trial designs, clearer post\u2011approval frameworks and priority pathways to streamline CGT development.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ebb8dee e-con-full e-flex e-con e-child\" data-id=\"ebb8dee\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-089f7d0 elementor-widget elementor-widget-heading\" data-id=\"089f7d0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Key Regulatory Accelerators<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4fb09d3 elementor-widget elementor-widget-text-editor\" data-id=\"4fb09d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong data-start=\"36\" data-end=\"55\" data-is-only-node=\"\">Smarter Trials:<\/strong> Adaptive designs and surrogate endpoints shorten timelines.<br data-start=\"115\" data-end=\"118\" \/><strong data-start=\"120\" data-end=\"146\">Post-Approval Clarity:<\/strong> Enables long-term follow-up and real-world data collection.<br data-start=\"206\" data-end=\"209\" \/><strong data-start=\"211\" data-end=\"229\">RMAT Leverage:<\/strong> Facilitates accelerated regulatory review of regenerative therapies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0c4f7d8 elementor-widget elementor-widget-image\" data-id=\"0c4f7d8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"1000\" src=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/4.jpg\" class=\"attachment-full size-full wp-image-6600\" alt=\"\" srcset=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/4.jpg 2000w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/4-300x150.jpg 300w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/4-1024x512.jpg 1024w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/4-768x384.jpg 768w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/4-1536x768.jpg 1536w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d3e9c17 e-con-full e-flex e-con e-child\" data-id=\"d3e9c17\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-25b1fd9 elementor-widget elementor-widget-heading\" data-id=\"25b1fd9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Clinical Impact\n<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4a3da71 elementor-widget elementor-widget-text-editor\" data-id=\"4a3da71\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"300\" data-end=\"470\">These frameworks cut CGT development time by up to 50%, bringing rare disease therapies to patients faster, with smarter trials and real-world data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c889dea elementor-widget elementor-widget-heading\" data-id=\"c889dea\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Why This Matters<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cb63a7a elementor-widget elementor-widget-text-editor\" data-id=\"cb63a7a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Adaptive designs + surrogate endpoints \u2192 <strong data-start=\"538\" data-end=\"564\" data-is-only-node=\"\">quicker trial readouts<\/strong> and earlier patient access.<\/li><li>Clearer post-approval expectations \u2192 <strong data-start=\"634\" data-end=\"664\">more real-world monitoring<\/strong> and long-term follow-up responsibilities for treating clinicians.<\/li><li>RMAT and priority pathways \u2192 <strong data-start=\"764\" data-end=\"786\">accelerated review<\/strong> for innovative CGTs, especially in rare and hard-to-treat cancers.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-204a25a e-con-full e-flex e-con e-child\" data-id=\"204a25a\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d58c16d elementor-widget elementor-widget-heading\" data-id=\"d58c16d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Take Home Point<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b40e868 elementor-widget elementor-widget-text-editor\" data-id=\"b40e868\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Prepare for <strong>more rapid adoption<\/strong> of early-approved CGTs and ensure systems are in place for vigilant post-marketing surveillance and timely referral to adaptive trials.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7b5cce6 e-flex e-con-boxed e-con e-parent\" data-id=\"7b5cce6\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-70100f2 elementor-widget elementor-widget-image\" data-id=\"70100f2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"230\" src=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/Logo_SunAct_V7_White-Logo-with-Tagline-scaled-e1767163609483-1024x294.avif\" class=\"attachment-large size-large wp-image-6685\" alt=\"\" srcset=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/Logo_SunAct_V7_White-Logo-with-Tagline-scaled-e1767163609483-1024x294.avif 1024w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/Logo_SunAct_V7_White-Logo-with-Tagline-scaled-e1767163609483-300x86.avif 300w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/Logo_SunAct_V7_White-Logo-with-Tagline-scaled-e1767163609483-768x220.avif 768w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/Logo_SunAct_V7_White-Logo-with-Tagline-scaled-e1767163609483-1536x440.avif 1536w, https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/Logo_SunAct_V7_White-Logo-with-Tagline-scaled-e1767163609483-2048x587.avif 2048w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddee517 elementor-widget elementor-widget-text-editor\" data-id=\"ddee517\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>At SunAct, we remain dedicated to tracking and sharing global advances that continue to redefine the landscape of cellular therapy and oncology. Stay tuned for our next edition as we uncover more breakthroughs and emerging trends shaping the future of cancer research.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5270095 e-flex e-con-boxed e-con e-parent\" data-id=\"5270095\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-90b3dda elementor-widget elementor-widget-text-editor\" data-id=\"90b3dda\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Disclaimer:<\/strong> This newsletter is intended for healthcare professionals and researchers. Information is for educational purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5c0914a elementor-widget elementor-widget-button\" data-id=\"5c0914a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/regisdigitals.com\/client\/Sunact\/wp-content\/uploads\/2025\/12\/OncoVantage-Volume-01-Issue-01-Dec-2025-1_compressed.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Download PDF<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Volume 1 issue 1 Insights into global breakthroughs in cell-based therapies Welcome to the SunAct Cancer Research Insights Newsletter, your monthly update on global breakthroughs shaping the next generation of cancer and cell-based therapies. In this issue, we explore pioneering advances in CGT\/ACT therapy, advancement in detection methods, and regulatory fast-tracks that are accelerating access [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-6566","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/pages\/6566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/comments?post=6566"}],"version-history":[{"count":0,"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/pages\/6566\/revisions"}],"wp:attachment":[{"href":"https:\/\/regisdigitals.com\/client\/Sunact\/wp-json\/wp\/v2\/media?parent=6566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}